Does the cancer vaccine work in both B-cell and T-cell lymphomas?
The BIOVAXID™ vaccine was originally developed and tested in B-cell lymphomas. The B-cell carries a unique special marker protein on its surface. It is this special marker on the B-cell that the vaccine is created to recognize. The vaccine has shown great promise in the treatment of B-cell lymphoma.